efavirenz has been researched along with Premature Birth in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Chagomerana, MB; DiPrete, BL; Harrington, BJ; Hosseinipour, MC; Jumbe, A; Kumwenda, W; Maliwichi, M; Phulusa, JN; Wallie, S; Wesevich, A | 1 |
| Benki-Nugent, S; Bulterys, MA; Chebet, D; Chege, M; Gomez, L; John-Stewart, G; King'e, M; Lawley, KA; Malavi, K; Moraa, H; Neary, J; Njuguna, I; Nzia, G; Onyango, A; Wagner, AD; Wamalwa, D | 1 |
| Cohan, D; Conroy, AL; Dorsey, G; Gamble, JL; Havlir, DV; Kain, KC; Kamya, MR; McDonald, CR; Natureeba, P; Olwoch, P | 1 |
| Chetty, T; Coutsoudis, A; Thorne, C | 1 |
| Diseko, M; Essex, M; Jacobson, DL; Lockman, S; Makhema, J; Mayondi, G; Mmalane, M; Petlo, C; Rough, K; Shapiro, RL; Zash, R | 1 |
| Cai, W; Fan, Q; Kourtis, AP; Shepard, C; Sun, L; Tao, J; Wang, L; Zhang, F; Zhao, H; Zhao, Q | 1 |
| Bernhardt, R; Brixius-Anderko, S; Fingerhut, R; Flück, CE; Grössl, M; Malikova, J; McDougall, J; Pandey, AV; Sluka, S; Zingg, T | 1 |
| Achan, J; Ades, V; Charlebois, ED; Clark, TD; Cohan, D; Havlir, DV; Kamya, MR; Koss, CA; Luwedde, F; Mwesigwa, J; Natureeba, P; Nzarubara, B; Plenty, A; Ruel, T | 1 |
| Amani-Bosse, C; Anglaret, X; Coffie, PA; Dabis, F; Danel, C; Eholié, SP; Ekouevi, DK; Messou, E; Moh, R; Ouattara, E; Sissoko, M | 1 |
1 trial(s) available for efavirenz and Premature Birth
| Article | Year |
|---|---|
Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Female; HIV Infections; Humans; Infant, Newborn; Lopinavir; Male; Pregnancy; Premature Birth; Risk Factors; Ritonavir; Uganda; Young Adult | 2014 |
8 other study(ies) available for efavirenz and Premature Birth
| Article | Year |
|---|---|
Three-year outcomes for women newly initiated on lifelong antiretroviral therapy during pregnancy - Malawi option B.
Topics: Female; HIV Infections; Humans; Infant; Infant, Newborn; Malawi; Male; Pregnancy; Premature Birth; Prospective Studies; Tenofovir | 2023 |
Neurodevelopment of children who are HIV-exposed and uninfected in Kenya.
Topics: Child; Child Development; Female; HIV Infections; Humans; Infant; Infant, Newborn; Kenya; Male; Mothers; Pregnancy; Pregnancy Complications, Infectious; Premature Birth | 2023 |
Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.
Topics: Adult; Alkynes; Angiopoietin-1; Angiopoietin-2; Anti-HIV Agents; Benzoxazines; Biomarkers; Cyclopropanes; Drug Combinations; Endoglin; Female; HIV Infections; Humans; Infant, Newborn; Infant, Small for Gestational Age; Lopinavir; Neovascularization, Physiologic; Placenta Growth Factor; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Premature Birth; Ritonavir; Stillbirth; Uganda; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2017 |
Preterm delivery and small-for-gestation outcomes in HIV-infected pregnant women on antiretroviral therapy in rural South Africa: Results from a cohort study, 2010-2015.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Small for Gestational Age; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Retrospective Studies; Rural Population; South Africa; Tenofovir; Young Adult | 2018 |
Effect of Gestational Age at Tenofovir-Emtricitabine-Efavirenz Initiation on Adverse Birth Outcomes in Botswana.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Botswana; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Fetal Death; Gestational Age; HIV Infections; Humans; Infant, Low Birth Weight; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Stillbirth; Tenofovir | 2018 |
Risk factors associated with preterm delivery and low delivery weight among HIV-exposed neonates in China.
Topics: Adult; Alkynes; Benzoxazines; China; Cross-Sectional Studies; Cyclopropanes; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Retrospective Studies; Risk Factors | 2018 |
HIV Drug Efavirenz Inhibits CYP21A2 Activity with Possible Clinical Implications.
Topics: Adrenal Hyperplasia, Congenital; Adult; Alkynes; Benzoxazines; Cell Line; Cyclopropanes; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Prenatal Exposure Delayed Effects; Reverse Transcriptase Inhibitors; Steroid 21-Hydroxylase | 2019 |
Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire.
Topics: Abortion, Induced; Abortion, Spontaneous; Adult; Africa, Western; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Retrospective Studies; Risk Assessment; Stillbirth | 2011 |